GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,777.50p
   
  • Change Today:
    -10.00p
  • 52 Week High: 1,901.50p
  • 52 Week Low: 1,264.00p
  • Currency: UK Pounds
  • Shares Issued: 4,075.43m
  • Volume: 487,362
  • Market Cap: £72,441m
  • RiskGrade: 129
  • Beta: 0.99

Latest ShareCast News

GSK to snap up Rapt Therapeutics in $2.2bn deal

By Abigail Townsend

Date: Tuesday 20 Jan 2026

(Sharecast News) - British drugs giant GSK has agreed to buy Rapt Therapeutics in a $2.2bn deal, it was announced on Tuesday, sending shares in the American allergy specialist soaring.

GSK ShareCast News

GSK chronic hepatitis B treatment hits goal in t... 07-Jan-2026 ShareCast
Japan approves GSK treatment for severe asthma 06-Jan-2026 ShareCast
GSK's COPD treatment approved by Chinese regulat... 05-Jan-2026 ShareCast
Director/PDMR Shareholding 22-Dec-2025 ShareCast
GSK to lower drug prices and expand access in US 22-Dec-2025 ShareCast

GSK Regulatory News

GSK to acquire RAPT Therapeutics 20-Jan-2026 07:05 RNS
Agreement on changes to ViiV minority shareholding 20-Jan-2026 07:00 RNS
Director/PDMR Shareholding 16-Jan-2026 15:30 RNS
Director/PDMR Shareholding 15-Jan-2026 15:30 RNS
Director/PDMR Shareholding 13-Jan-2026 15:30 RNS

GSK Newspaper Links

GSK to buy US food allergy specialist for $2.2bn 20-Jan-2026 Times
GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph
Ebola vaccine trials 'encouraging', says GSK 27-Nov-2014 Telegraph

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,777.50p
Change Today -10.00p
% Change -0.56 %
52 Week High 1,901.50p
52 Week Low 1,264.00p
Volume 487,362
Shares Issued 4,075.43m
Market Cap £72,441m
Beta 0.99
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 13
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q3 Q2
Ex-Div 13-Nov-25 14-Aug-25
Paid 08-Jan-26 09-Oct-25
Amount 16.00p 16.00p

Trades for 22-Jan-2026

Time Volume / Share Price
09:23 1 @ 1,778.00p
09:23 0 @ 1,778.00p
09:23 200 @ 1,778.00p
09:23 200 @ 1,777.50p
09:23 950 @ 1,777.50p

GSK Key Personnel

CEO Luke Miels

Top of Page